Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
28/08/2026 13:00
BRIEF-Xortx Announces Termination And Postponement Of Investor Relations Program Aug 28 (Reuters) - XORTX Therapeutics Inc XRTX.V:
XORTX ANNOUNCES TERMINATION AND POSTPONEMENT OF INVESTOR RELATIONS PROGRAM
XORTX THERAPEUTICS - EXPECTS VOLUNTARY DELISTING FROM TSXV TO TAKE EFFECT SEPTEMBER 1, 2026
Source text: ID:nGNX323j3C
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering